Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4369-4380
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4369
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4369
Group | Damage score, 0-101 | Extension of lesion, cm2 | Colonic weight, mg/cm2 | Diarrhea3 | Adherence3 |
Non-colitic | 0a | 0a | 82.7 ± 2.10a | 0%a | 0%a |
TNBS-control | 7 (2-8) | 2.55 ± 0.28 | 136.0 ± 5.87 | 87.50% | 81.25% |
PACO2 - 25 mg/kg | 7 (5-8) | 2.44 ± 0.18 | 135.0 ± 6.86 | 100.00% | 71.42% |
PACO2 - 50 mg/kg | 7 (2-9) | 2.11 ± 0.34 | 124.0 ± 7.72 | 85.71% | 71.42% |
PACO2 - 100 mg/kg | 7 (4-9) | 2.93 ± 0.20 | 162.0 ± 5.04 | 100.00% | 57.14% |
- Citation: Almeida Junior LD, Quaglio AEV, de Almeida Costa CAR, Di Stasi LC. Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation. World J Gastroenterol 2017; 23(24): 4369-4380
- URL: https://www.wjgnet.com/1007-9327/full/v23/i24/4369.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i24.4369